DYN ▲ +1.0% - Dyne Therapeutics, Inc.
$DYN - Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
29-SEP-2026 04:05 PM ET
Share this post
More filings for $DYN
DYN ▲ +4.3% - Dyne Therapeutics, Inc.Sep 17, 2026DYN ▼ -5.1% - Dyne Therapeutics, Inc.Sep 9, 2026DYN ▼ -28.5% - Dyne Therapeutics, Inc.Sep 8, 2026DYN ▲ +0.4% - Dyne Therapeutics, Inc.Sep 3, 2026DYN ▼ -0.1% - Dyne Therapeutics, Inc.Sep 2, 2026DYN - Dyne Therapeutics, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $DYN filing history →💬 Comments
Loading comments…
Leave a comment